Webinars

Search results on Pharma Manufacturing & Supply Chain

431 Results

August 18, 2026

Improve Biologic Modalities Manufacturing for mAb Readiness
Hero - Desktop
July 30, 2026

Avoiding Costly Rework During Biopharmaceutical Scale-Up
Hero - Desktop
July 21, 2026

Reducing Downstream Bottlenecks with Pre-packed Chromatography Columns
Hero - Desktop
June 23, 2026

De-Risk USP Compliance for Single-Use Systems
Hero - Desktop
June 23, 2026

AI and Automation in Artwork & Labelling for Life Sciences: Advancing Quality and Efficiency
Hero - Desktop
June 18, 2026

Reduce Supply Chain Delays in Life Sciences Manufacturing
Hero - Desktop
June 17, 2026

Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy
Hero - Desktop
June 15, 2026

AI-driven Rapid Response In Supply Chains With Lower Cost To Serve
Hero - Desktop
June 09, 2026

Innovating Peptide Manufacturing Through Modular Design and Process Intensification
Hero - Desktop
June 08, 2026

Improve Fill-Finish Yield for Today’s High-Value Drug Products
Hero - Desktop
June 08, 2026

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays
Hero - Desktop
June 03, 2026

Reduce Supply Risk with RTSM Designs for Radiopharmaceutical Trials
Hero - Desktop
June 03, 2026

Scaling Cell Line Development: Enabling IND-Ready, GMP-Compatible Workflows (Broadcast 2)
Hero - Desktop
June 02, 2026

Optimize Yield and Compliance With AI-Enabled Pharma Manufacturing
Hero - Desktop
June 02, 2026

Scaling Cell Line Development: Enabling IND-Ready, GMP-Compatible Workflows (Broadcast 1)
Hero - Desktop
May 27, 2026

Accelerating CHO Process Optimization for Faster Scale-Up Readiness
May 12, 2026

Media Manufacturing Strategies to Reduce GMP Transition Risk
Hero - Desktop
April 21, 2026

De-Risk Supply Disruptions Through Flexible Manufacturing Capacity
FormulatedSolutions_Hero 1600x400
April 15, 2026

Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development
March 30, 2026

The $90B Leakage Problem: What Pharma Must Know About Gross-to-Net (GTN) Risk